92 related articles for article (PubMed ID: 6393665)
1. Danish Breast Cancer Cooperative Group (DBCG). Present status and experience.
Fischerman K; Mouridsen HT
Acta Chir Scand Suppl; 1984; 519():55-9. PubMed ID: 6393665
[TBL] [Abstract][Full Text] [Related]
2. Danish Breast Cancer Cooperative Group--DBCG: History, organization, and status of scientific achievements at 30-year anniversary.
Blichert-Toft M; Christiansen P; Mouridsen HT
Acta Oncol; 2008; 47(4):497-505. PubMed ID: 18465316
[TBL] [Abstract][Full Text] [Related]
3. Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry.
Mouridsen HT; Bjerre KD; Christiansen P; Jensen MB; Møller S
Acta Oncol; 2008; 47(4):525-36. PubMed ID: 18465318
[TBL] [Abstract][Full Text] [Related]
4. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
5. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
; Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
J Clin Oncol; 2006 May; 24(15):2268-75. PubMed ID: 16618947
[TBL] [Abstract][Full Text] [Related]
6. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise.
Møller S; Jensen MB; Ejlertsen B; Bjerre KD; Larsen M; Hansen HB; Christiansen P; Mouridsen HT;
Acta Oncol; 2008; 47(4):506-24. PubMed ID: 18465317
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy.
Overgaard M
Rays; 2000; 25(3):325-30. PubMed ID: 11367898
[TBL] [Abstract][Full Text] [Related]
8. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001.
Andersson M; Jensen MB; Engholm G; Henrik Storm H
Acta Oncol; 2008; 47(4):755-64. PubMed ID: 18465345
[TBL] [Abstract][Full Text] [Related]
9. [Breast cancer in the county of Viborg during 1983-1989. A quality control study].
Nielsen JC; Andersen E; Zedeler K
Ugeskr Laeger; 1994 May; 156(18):2737-41. PubMed ID: 8009713
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
11. Recurrence pattern and prognosis in low-risk breast cancer patients--data from the DBCG 89-A programme.
Christiansen P; Al-Suliman N; Bjerre K; Møller S;
Acta Oncol; 2008; 47(4):691-703. PubMed ID: 18465337
[TBL] [Abstract][Full Text] [Related]
12. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.
Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
Radiother Oncol; 2006 May; 79(2):147-55. PubMed ID: 16647152
[TBL] [Abstract][Full Text] [Related]
13. Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer.
Andersen KW; Mouridsen HT
Acta Oncol; 1988; 27(6A):627-47. PubMed ID: 3064772
[TBL] [Abstract][Full Text] [Related]
14. Breast conserving treatment in Denmark, 1989-1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group.
Ewertz M; Kempel MM; Düring M; Jensen MB; Andersson M; Christiansen P; Kroman N; Rasmussen BB; Overgaard M
Acta Oncol; 2008; 47(4):682-90. PubMed ID: 18465336
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
[TBL] [Abstract][Full Text] [Related]
16. Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study.
Willemoe GL; Hertel PB; Bartels A; Jensen MB; Balslev E; Rasmussen BB; Mouridsen H; Ejlertsen B; Brünner N
Eur J Cancer; 2009 Sep; 45(14):2528-36. PubMed ID: 19535243
[TBL] [Abstract][Full Text] [Related]
17. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
Fodor J; Polgár C; Németh G
Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
[TBL] [Abstract][Full Text] [Related]
18. DBCG: the Danish Breast Cancer Cooperative Group--a 30-year struggle for better breast cancer treatment in Denmark.
Overgaard J
Acta Oncol; 2008; 47(4):491-6. PubMed ID: 18465315
[No Abstract] [Full Text] [Related]
19. Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group.
Kroman N; Jensen MB; Wohlfahrt J; Ejlertsen B;
Acta Oncol; 2008; 47(4):545-9. PubMed ID: 18465320
[TBL] [Abstract][Full Text] [Related]
20. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
